Our trial of ondansetron as a treatment for hallucinations in Parkinson's is restarting Date 22 November 2024
Further clues about alpha-synuclein Date 11 February 2021 New research has advanced our understanding of a protein called alpha-synuclein, which is believed to play a central role in damaging brain cells in Parkinson’s.
Vision tests predict cognitive decline linked to Parkinson's Date 19 January 2021 Scientists in the UK have uncovered evidence that simple vision tests can predict who will develop Parkinson's dementia. And the evidence shows that a loss of wiring in the brain may be the cause.
New guidance for lab-based researchers on patient and public involvement Date 8 January 2021 We’ve partnered with Alzheimer’s Society and University College London Hospitals (UCLH) Biomedical Research Centre. Together, we’ve developed a new resource to help lab-based researchers with patient and public involvement (PPI).
New trial to drive forward promising treatment for dyskinesia Date 22 November 2020 Parkinson’s UK is joining forces with US charity The Michael J. Fox Foundation and biopharma company Neurolixis to fund a £1.5m clinical trial of an exciting new drug to combat dyskinesia in people with Parkinson’s.
Caption Husband and wife look out the window Could an anti-sickness drug treat hallucinations in Parkinson's? Date 25 October 2020 We're funding a new research study into a possible treatment for hallucinations in Parkinson's.
Research finds air pollution may speed up Parkinson's Date 19 October 2020 Researchers in the US have uncovered a link between long-term exposure to pollution and deterioration in health conditions. This includes Parkinson's and Alzheimer's.
Oxford researchers find molecule that may slow or stop the progress of Parkinson's Date 29 September 2020 Parkinson's UK funded research suggests it may be possible to prevent the formation of protein clumps that cause problems in Parkinson's by using microscopic tweezers that pull apart the proteins. This could pave the way for a therapy that could slow or stop the progression of the condition.
Trial results show statin drug does not slow Parkinson's Date 14 September 2020 Simvastatin is a drug already used to lower cholesterol, and prevent heart attacks and strokes. Initial results from a major clinical trial show it doesn't have potential to slow the progression of Parkinson's as previously hoped.
Research shows bad dreams could predict future memory and thinking problems Date 14 August 2020 Researchers in Portugal have discovered that the content of dreams, particularly those with negative emotions, may predict long-term cognitive decline in people with Parkinson’s.
Link found between diabetes and increased Parkinson’s risk Date 11 August 2020 An international team of researchers have uncovered a biological link that may account for why those with diabetes have a higher risk of developing Parkinson’s.
